News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Followwill Dorman
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
3
| Followwill Dorman (Director) has filed a Form 3 on Vickers Vantage Corp. I |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Acquired (by will) 1,000 shares
@ $0
Sold 1,000 shares
@ $7.135, valued at
$7.1k
|
|
| 06/15/2020 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $4.89, valued at
$489k
|
|
| 04/23/2019 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 70,000 options
@ $3.78, valued at
$264.6k
|
|
| 11/27/2018 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 35,000 options
@ $3.57, valued at
$125k
|
|
| 11/16/2017 |
4
| Followwill Dorman (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 35,000 options
@ $2.3, valued at
$80.5k
|
|
| 10/02/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|